Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study.

Onland W, Debray TP, Laughon MM, Miedema M, Cools F, Askie LM, Asselin JM, Calvert SA, Courtney SE, Dani C, Durand DJ, Marlow N, Peacock JL, Pillow JJ, Soll RF, Thome UH, Truffert P, Schreiber MD, Van Reempts P, Vendettuoli V, Vento G, van Kaam AH, Moons KG, Offringa M.

BMC Pediatr. 2013 Dec 17;13:207. doi: 10.1186/1471-2431-13-207. Review.

2.

Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.

Onland W, De Jaegere AP, Offringa M, van Kaam A.

Cochrane Database Syst Rev. 2017 Jan 31;1:CD010941. doi: 10.1002/14651858.CD010941.pub2. Review.

PMID:
28141913
3.

Addition of SNAP to perinatal risk factors improves the prediction of bronchopulmonary dysplasia or death in critically ill preterm infants.

Li Y, Yan J, Li M, Xiao Z, Zhu X, Pan J, Li X, Feng X.

BMC Pediatr. 2013 Sep 10;13:138. doi: 10.1186/1471-2431-13-138.

4.

Bronchopulmonary dysplasia prediction model for 7-day-old infants.

Bhering CA, Mochdece CC, Moreira ME, Rocco JR, Sant'Anna GM.

J Pediatr (Rio J). 2007 Mar-Apr;83(2):163-70. Epub 2007 Mar 20.

5.

Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis.

Isayama T, Iwami H, McDonald S, Beyene J.

JAMA. 2016 Aug 9;316(6):611-24. doi: 10.1001/jama.2016.10708. Review. Erratum in: JAMA. 2016 Sep 13;316(10):1116.

PMID:
27532916
6.

Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.

Shah SS, Ohlsson A, Halliday HL, Shah VS.

Cochrane Database Syst Rev. 2017 Oct 17;10:CD002058. doi: 10.1002/14651858.CD002058.pub3. Review.

PMID:
29041034
7.

Early Cumulative Supplemental Oxygen Predicts Bronchopulmonary Dysplasia in High Risk Extremely Low Gestational Age Newborns.

Wai KC, Kohn MA, Ballard RA, Truog WE, Black DM, Asselin JM, Ballard PL, Rogers EE, Keller RL; Trial of Late Surfactant (TOLSURF) Study Group.

J Pediatr. 2016 Oct;177:97-102.e2. doi: 10.1016/j.jpeds.2016.06.079. Epub 2016 Jul 26.

8.

Predictors of bronchopulmonary dysplasia.

Trembath A, Laughon MM.

Clin Perinatol. 2012 Sep;39(3):585-601. doi: 10.1016/j.clp.2012.06.014. Review.

10.

Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.

Bassler D.

Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5. Review.

PMID:
26044104
11.

Pentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infants.

Schulzke SM, Kaempfen S, Patole SK.

Cochrane Database Syst Rev. 2014 Nov 24;(11):CD010018. doi: 10.1002/14651858.CD010018.pub2. Review.

PMID:
25418278
12.

Small thymus at birth: a predictive radiographic sign of bronchopulmonary dysplasia.

De Felice C, Latini G, Del Vecchio A, Toti P, Bagnoli F, Petraglia F.

Pediatrics. 2002 Aug;110(2 Pt 1):386-8.

PMID:
12165595
13.

Untargeted Metabolomic Analysis of Amniotic Fluid in the Prediction of Preterm Delivery and Bronchopulmonary Dysplasia.

Baraldi E, Giordano G, Stocchero M, Moschino L, Zaramella P, Tran MR, Carraro S, Romero R, Gervasi MT.

PLoS One. 2016 Oct 18;11(10):e0164211. doi: 10.1371/journal.pone.0164211. eCollection 2016.

14.

Association between Breast Milk and Bronchopulmonary Dysplasia: A Single Center Observational Study.

Fonseca LT, Senna DC, Silveira RC, Procianoy RS.

Am J Perinatol. 2017 Feb;34(3):264-269. doi: 10.1055/s-0036-1586503. Epub 2016 Aug 3.

PMID:
27487230
15.
16.

Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.

Laughon MM, Langer JC, Bose CL, Smith PB, Ambalavanan N, Kennedy KA, Stoll BJ, Buchter S, Laptook AR, Ehrenkranz RA, Cotten CM, Wilson-Costello DE, Shankaran S, Van Meurs KP, Davis AS, Gantz MG, Finer NN, Yoder BA, Faix RG, Carlo WA, Schibler KR, Newman NS, Rich W, Das A, Higgins RD, Walsh MC; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.

Am J Respir Crit Care Med. 2011 Jun 15;183(12):1715-22. doi: 10.1164/rccm.201101-0055OC. Epub 2011 Mar 4.

17.

A clinical scoring system to predict the development of bronchopulmonary dysplasia.

Gursoy T, Hayran M, Derin H, Ovali F.

Am J Perinatol. 2015 Jun;32(7):659-66. doi: 10.1055/s-0034-1393935. Epub 2014 Oct 6.

PMID:
25285400
18.

[Risk factors, frequency and severity of bronchopulmonary dysplasia (BPD) diagnosed according to the new disease definition in preterm neonates].

Woynarowska M, Rutkowska M, Szamotulska K.

Med Wieku Rozwoj. 2008 Oct-Dec;12(4 Pt 1):933-41. Polish.

PMID:
19471069
19.

Epidemiological factors involved in the development of bronchopulmonary dysplasia in very low birth-weight preterm infants.

Lardón-Fernández M, Uberos J, Molina-Oya M, Narbona-López E.

Minerva Pediatr. 2017 Feb;69(1):42-49. doi: 10.23736/S0026-4946.16.04215-8. Epub 2015 Feb 25.

PMID:
25715027
20.

Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.

Shah SS, Ohlsson A, Halliday HL, Shah VS.

Cochrane Database Syst Rev. 2017 Oct 16;10:CD002057. doi: 10.1002/14651858.CD002057.pub4. Review.

PMID:
29035425

Supplemental Content

Support Center